DOCSLIB.ORG

2015 Research Annual Report Table of Contents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2015 Research Annual Report Table of Contents 2015 Research Annual Report Table of Contents SUMMARIES OF 2015 NATIONAL INSTITUTES OF HEALTH GRANTS AWARDED TO HFHS PART I - INTERNAL MEDICINE DEPARTMENT ALLERGY AND IMMUNOLOGY .................................................................................. 1 CARDIOLOGY/CARDIOVASCULAR RESEARCH ........................................................... 1 ENDOCRINOLOGY AND METABOLISM ....................................................................... 2 HYPERTENSION AND VASCULAR RESEARCH ............................................................ 3 SLEEP MEDICINE .................................................................................................. 6 PART II - ALL OTHER CLINICAL DEPARTMENTS DERMATOLOGY .................................................................................................... 8 IMAGING RESEARCH PROGRAM.............................................................................. 9 NEUROLOGY ...................................................................................................... 10 RADIATION ONCOLOGY ....................................................................................... 17 UROLOGY .......................................................................................................... 18 PART III – POPULATION SCIENCES CENTER FOR HEALTH POLICY AND HEALTH SERVICES RESEARCH ........................... 19 DEPARTMENT OF PUBLIC HEALTH SCIENCES ......................................................... 21 PUBLICATIONS ADMINISTRATION……………………………………………………………….…….....………30 ALLERGY AND IMMUNOLOGY…………………………………………………….………...30 ANESTHESIOLOGY………………………………………………………………………….32 BEHAVIORAL HEALTH SERVICES……………………………………………………….….32 BIORESOURCES ........................................................................................................ 34 CARDIOLOGY/CARDIOVASCULAR RESEARCH…………………………………..……….…34 CENTER FOR HEALTH POLICY AND HEALTH SERVICES RESEARCH………………………51 COMMUNITY CARE SERVICES………………………………………….…………………..56 DERMATOLOGY………………………………………………….…………………….… 56 DIAGNOSTIC RADIOLOGY…………………………………………………………………...64 DIALYSIS ADMINISTRATION…………………………………………………….…………..66 EMERGENCY MEDICINE……………………………………………………..…………..….66 ENDOCRINOLOGY…………………………………………………………………...……...72 FAMILY MEDICINE……………………………………………………………………..……73 GASTROENTEROLOGY…………………………………………………………………..….74 GENETICS………………………………………………………………………...……...……...85 GLOBAL HEALTH INITIATIVE……………………………………………..…………………85 GRADUATE MEDICAL EDUCATION………………………………………………………….86 HEMATOLOGY, ONCOLOGY AND THE JOSEPHINE FORD CANCER INSTITUTE….…….....….86 HEMOPHILIA AND THROMBOSIS TREATMENT CENTER…………………………....……….91 HOME HEALTH CARE……………………………………………………………….………91 HYPERTENSION AND VASCULAR RESEARCH………………………………………………92 INFECTIOUS DISEASES…………………………………………………...……………..….93 INTERNAL MEDICINE………………………………………………...………………...…...96 NEPHROLOGY……………………………………………………….…….………………108 NEUROLOGY………………………………………………………………….…………....112 NEUROSURGERY…………………………………………………………….………….....121 NURSING……………………………………………………………………………….………129 OBSTETRICS, GYNECOLOGY AND WOMEN’S HEALTH SERVICES…………………….…..129 OPTHALMOLOGY AND EYE CARE SERVICES………………………………………….…..133 ORTHOPAEDICS…………………………………………………………………………...133 OTOLARYNOLOGY…………………………………………………………………………136 PATHOLOGY……………………………………………………………………………….140 PEDIATRIC MEDICINE……………………………………………...………………………147 PHARMACY………………………………………………………………………...………147 PSYCHOLOGY… ..................................................................................................... 149 PUBLIC HEALTH SCIENCES………………………………………………………………..149 PULMONARY……………………………………………………………………………….167 RADIATION ONCOLOGY……………………………………………………………………171 RADIOLOGY………………………………………………………………………………..182 RESEARCH ADMINISTRATION…………………………………………...…………………187 RHEUMATOLOGY…………………………………………………………………………..188 SLEEP MEDICINE…………………………………………………..………………………189 SPORTS MEDICINE………………………………………………………..……………….193 SURGERY……………………………………………………...…………………………..193 UROLOGY……………………………………………………………...…………………..202 Summaries of 2015 National Institutes of Health Grants Awarded to HFHS Part I –Department of Internal Medicine • Allergy and Immunology • Cardiology/Cardiovascular Research • Endocrinology and Metabolism • Hypertension and Vascular Research • Sleep Medicine Allergy and Immunology Principal Investigator: Edward Zoratti, M.D. Pets and the Infant Microbiome: Effect on Immune Maturation & Atopic Asthma– Project 2 (NIH P01A1089473-01A1) The Program Project Grant (PPG) application seeks an increased understanding of the relationships between dog or cat exposure during infancy and a lower risk of allergic asthma. We believe that this protective association is related to different patterns of microbial stimulation during immune development. Four synergistic Projects will examine our hypothesis that the presence of pets in a home results in a more diverse bacterial community composition (BCC) of the dust in the home which in turn influences the development of the gut BCC of a newborn infant living in the home. A more diverse gut BCC shifts the maturation of the infant's immune system such that later immune responses are less likely to produce IgE antibody responses and allergic asthma. Project 2 will recruit a new birth cohort of children either living with or without a dog, measure infant stool BCC, and follow the cohort with detailed studies of immune function until 18 months of age to determine the impact of dog exposure on immune maturation. The Projects are supported by five Cores which each provide essential services to all four Projects. Cardiology/CardiovascularResearch Principal Investigator: David Lanfear,M.D. Impact of Race and Genetic Factors on Beta-Blocker Effectiveness in Heart Failure (NIH 1R01HL103871-03) Heart failure (HF) is an enormous public health problem with over 500,000 cases annually, and African American individuals share a disproportionate amount of this burden including a higher prevalence and mortality when compared with white individuals. Beta adrenergic antagonists (beta-blockers, BB) are the foundation of modern HF care, but their effectiveness in African Americans is not clear. Pivotal clinical trials of BB in HF were woefully underpowered to assess African American patients, and many experts have suggested a differential BB benefit in African American patients when compared with white patients. 1 This issue requires additional data and clarity because improved understanding and elimination of such disparities is a national research priority (Healthy People 2010). Multiple factors may contribute to a racial disparity in BB effect such as genetic factors, medication adherence, and comorbid illnesses. All of these factors must be characterized in detail in order to evaluate which factor(s) contribute to this. Existing pharmacogenetic studies have suggested that specific variants may explain racial differences in BB effectiveness, but these studies have not quantified drug exposure or adherence and have not included a sufficient number of African Americans. In order to answer these questions, we propose a racially diverse, prospective, pharmacogenomic registry of 1000 HF patients. Our center has important advantages to achieve this including the fact that roughly half of our HF patients are African American, and we have experience and infrastructure in quantifying adherence and drug exposure using pharmacy claims data. Using this cohort we will assess the influence of race and genetic factors on BB effectiveness, measured by clinical events (time to hospitalization or death) and health status. Ultimately these data will clarify the benefit of BB in African Americans, and contribute to improved targeting of BB therapy to those with highest likelihood of favorable response while avoiding those likely to respond unfavorably. Public Health Relevance: Heart failure is an enormous public health problem and African American individuals share a disproportionate amount of this burden including a higher prevalence and mortality when compared with white individuals. Beta blockers are the foundation of modern heart failure care, but their effectiveness in African American individuals is not clear. This project seeks to clarify whether beta blockers are equally effective in African American patients when compared with white patients and identify the underlying factors that impact this difference, particularly genetic factors. Endocrinology and Metabolism Principal Investigator: D. Sudhaker Rao, M.D. Pathogenesis of Atypical Femaur Fractures on Long Term Bisphosphonate Therapy (NIH 1R01AR062103-01A1) Bisphosphonates (BP) have been used successfully for over a decade to prevent and treat osteoporosis and reduce osteoporotic fractures. However, since 2005 there have been many reports of atypical femoral fractures (AFF) in patients on prolonged BP therapy. Recently, it has been found that a prodromal bone deterioration (PBD) usually appears before the development to AFF. However, many PBDs may be asymptomatic, not necessarily progress to AFF, and heal spontaneously after discontinuation of BP therapy. Therefore, the prevalence of PBD may be much higher than AFF. To date, there is no evidence to support this hypothesis. It has been reported that many patients with PBD and AFF have severely suppressed bone turnover (SSBT). However, since not all patients with PBD/AFF also have SSBT, factors other than SSBT might contribute to the development of PBD/AFF. Our preliminary study suggests that PBD/AFF may be associated with osteocyte death, bone hypermineralization, and microdamage accumulation which compromise
Load more

Recommended publications
  • FMB Ch05-Gerwick.Indd
    PB Marine Cyanobacteria Ramaswamy et al. 175 5 The Secondary Metabolites and Biosynthetic Gene Clusters of Marine Cyanobacteria. Applications in Biotechnology Aishwarya V. Ramaswamy, Patricia M. Flatt, Daniel J. Edwards, T. Luke Simmons, Bingnan Han and William H. Gerwick* Abstract Marine cyanobacteria have proven to be one of the most versatile marine producers of secondary metabolites. Many of these metabolites demonstrate antiproliferative activity (e.g. curacin A, dolastatins), acute cytotoxic activity (e.g. apratoxin, hectochlorin) or have specific neurotoxic activity (e.g. kalkitoxin, antillatoxin), making them invaluable as potential therapeutic leads or pharmacological tools. The predominant biogenetic theme in cyanobacterial natural products chemistry is the integration of polyketide synthases (PKS) and nonribosomal peptide synthetases (NRPS) along with a variety of unusual tailoring or modifying enzymes, and accounts for the tremendous structural diversity of their metabolites. Only recently has the genetic architecture of several cyanobacterial biosynthetic gene clusters been determined, and studies to understand and exploit this biosynthentic machinery present an exciting new frontier. This chapter will summarize the properties of several notable metabolites from marine cyanobacteria that have clinical or pharmacological applications followed by a detailed account of their biosyntheses at the molecular genetic level and their potential applications in biotechnology. 1. Introduction Cyanobacteria, also known as blue-green algae, are ancient (ca. 2 x 109 years) photosynthetic prokaryotes which inhabit a wide diversity of habitats including *For correspondence email [email protected] 176 Marine Cyanobacteria Ramaswamy et al. 177 open oceans, tropical reefs, shallow water environments, terrestrial substrates, aerial environments such as in trees and rock faces, and fresh water ponds, streams and puddles (Whitton and Potts, 2000) .
    [Show full text]
  • Marine Drugs
    Mar. Drugs 2015, 13, 1552-1568; doi:10.3390/md13031552 OPEN ACCESS marine drugs ISSN 1660-3397 www.mdpi.com/journal/marinedrugs Article Kalkitoxin Inhibits Angiogenesis, Disrupts Cellular Hypoxic Signaling, and Blocks Mitochondrial Electron Transport in Tumor Cells J. Brian Morgan 1, Yang Liu 1, Veena Coothankandaswamy 1, Fakhri Mahdi 1, Mika B. Jekabsons 2, William H. Gerwick 3, Frederick A. Valeriote 4, Yu-Dong Zhou 1,*, and Dale G. Nagle 1,* 1 Department of BioMolecular Sciences and Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA; E-Mails: [email protected] (J.B.M.); [email protected] (Y.L.); [email protected] (V.C.); [email protected] (F.M.) 2 Department of Biology, University of Mississippi, University, MS 38677, USA; E-Mail: [email protected] 3 Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 920933, USA; E-Mail: [email protected] 4 Department of Internal Medicine, Division of Hematology and Oncology, Henry Ford Hospital, Detroit, MI 48202, USA; E-Mail: [email protected] * Authors to whom correspondence should be addressed; E-Mails: [email protected] (D.G.N.); [email protected] (Y.-D.Z.); Tel.: +1-662-915-7143; Fax: +1-662-915-5638. Academic Editors: Sergey A. Dyshlovoy and Friedemann Honecker Received: 29 January 2015 / Accepted: 11 March 2015 / Published: 20 March 2015 Abstract: The biologically active lipopeptide kalkitoxin was previously isolated from the marine cyanobacterium Moorea producens (Lyngbya majuscula). Kalkitoxin exhibited N-methyl-D-aspartate (NMDA)-mediated neurotoxicity and acted as an inhibitory ligand for voltage-sensitive sodium channels in cultured rat cerebellar granule neurons.
    [Show full text]
  • Cianobakterijski Toksini in Njihov Vpliv Na Zdravje Cyanobacterial Toxins and Their Effect on Health
    Cianobakterijski toksini in njihov vpliv na zdravje Cyanobacterial toxins and their effect on health Dušan Šuput, University of Ljubljana, Faculty of Medicine Cyanobacterial toxins • From anthropocentric view cyanobacteria are harmful organisms producing two main classes of toxins: neurotoxins and hepatotoxins. • Acute intoxications with neurotoxins are relatively common and usually present as shellfish poisoning. • Acute intoxications with hepatotoxic cyanopeptides are relatively rare, but life threatening human intoxications and fatalities have also occurred Cyanobacterial neurotoxins Neurotoxic lipopeptides Antillatoxin, jamaicamides, hermitamide and kalkitoxin are neurotoxic lipopeptides produced by marine cyanobacteria. Some of them are sodium channel activators and the others have an opposite action: they inhibit voltage-gated sodium channels. Neurotoxic alkaloids They can be divided in three groups: 1) anatoxins acting on cholinergic system 2) saxitoxins that block voltage gated sodium channels and 3) unusual, non-proteinogenic amino acids: 1. Anatoxins Anatoxins present a serious health hazard. They reach food chain and cause severe neurotoxicity. Anatoxin-a and homoanatoxin-a are powerful agonists of nicotinic AChR causing depolarization of muscle membranes. This initiates twitches progressing to generalized fasciculations and finally muscular weakness. Anatoxin-a(s) is different from anatoxin-a and homoanatoxin-a. It is an organophosphate produced by cyanobacteria. Like chemical warfare agents sarin and soman it irreversibly binds to AChE, an enzyme responsible for the cessation of ACh action in cholinergic synapses. 2. Saxitoxins Saxitoxins comprise over 50 structurally related molecules produced by dinoflagellates and by some freshwater cyanobacteria. They are a common cause of paralytic shellfish poisoning (PSP) as they bind to nerve and muscle sodium channels with 20 to 60 times higher affinity than to sodium channels in heart muscle and in denervated skeletal muscle • 3.
    [Show full text]
  • The Autocrine Excitotoxicity of Antillatoxin, a Novel
    THE AUTOCRINE EXCITOTOXICITY OF ANTILLATOXIN, A NOVEL LIPOPEPTIDE DERIVED FROM THE PANTROPICAL MARINE CYANOBACTERIUM LYNGBYA majuscula by JOHN MICHAEL MOULTON (Under the D rect on of Dr. Thomas Murray) ABSTRACT Ant llatoxin (ATX) is a l popept de produce d by the mar ne cyanobacter um . Lyngbya majuscula . ATX, a Na channel act vator, produces N 0methyl 0D0aspartate (NMDA) receptor mediated neurotox c ty in rat cerebellar granule neurons (C2Ns). To determ ne whether ATX produced this neurotox c ty throu1h an ndirect mechanism, the nfluence of ATX on 1lutamate release 3as ascerta ned. ATX produced a concentrat on0 dependent increase in e,tracellular 1lutamate. This response was prevented by the Na . channel anta1onist tetrodotox n (TTX). ATX caused a stron1 membrane depolar 4at on 3 th a ma1nitude comparable to that of 100 mM KCL. ATX also produced concentrat on0dependent cytotox c ty as measured by lactate dehydro1enase act vity. Ca .2 influ, was measured us ng a fluorescent ima1 n1 plate reader (FLIPR). AT X produced concentrat on0dependent Ca .2 influx. The neurotox c mechanisms of ATX are therefore s m lar to those of brevetox ns, which produce neuronal injury through depolar 4at on0 nduced Na .1 load, glutamate release, rel ef of M1 .2 block of NMDA recepto rs, and Ca .2 influx. INDEX WORDS: Neurotox n, E,c toto, c ty, Glutamate, Sodium Channel, FLIPR, Cerebellar Granule Neurons THE AUTOCRINE EXCITOTOXICITY OF ANTILLATOXIN, A NOVEL LIPOPEPTIDE DERIVED FROM THE ANTROPICAL MARINE CYANOBACTERIUM LYNGBYA majuscula by JOHN MICHAEL MOULTON
    [Show full text]
  • The Diversity of Cyanobacterial Toxins on Structural Characterization, Distribution and Identification: a Systematic Review
    toxins Review The Diversity of Cyanobacterial Toxins on Structural Characterization, Distribution and Identification: A Systematic Review Xingde Du 1, Haohao Liu 1, Le Yuan 1, Yueqin Wang 1, Ya Ma 1, Rui Wang 1, Xinghai Chen 2, Michael D. Losiewicz 2, Hongxiang Guo 3,* and Huizhen Zhang 1,* 1 College of Public Health, Zhengzhou University, Zhengzhou 450001, China; [email protected] (X.D.); [email protected] (H.L.); [email protected] (L.Y.); [email protected] (Y.W.); [email protected] (Y.M.); [email protected] (R.W.) 2 Department of Chemistry and Biochemistry, St Mary’s University, San Antonio, TX 78228, USA; [email protected] (X.C.); [email protected] (M.D.L.) 3 College of Life Sciences, Henan Agricultural University, Zhengzhou 450002, China * Correspondence: [email protected] (H.Z.); [email protected] (H.G.); Tel.: +86-151-8835-7252 (H.Z.); +86-136-4386-7952 (H.G.) Received: 27 August 2019; Accepted: 9 September 2019; Published: 12 September 2019 Abstract: The widespread distribution of cyanobacteria in the aquatic environment is increasing the risk of water pollution caused by cyanotoxins, which poses a serious threat to human health. However, the structural characterization, distribution and identification techniques of cyanotoxins have not been comprehensively reviewed in previous studies. This paper aims to elaborate the existing information systematically on the diversity of cyanotoxins to identify valuable research avenues. According to the chemical structure, cyanotoxins are mainly classified into cyclic peptides, alkaloids, lipopeptides, nonprotein amino acids and lipoglycans. In terms of global distribution, the amount of cyanotoxins are unbalanced in different areas.
    [Show full text]
  • Novel Bioactive Secondary Metabolites from the Marine Cyanobacteriumlyngbya Majuscula
    AN ABSTRACT OF THE THESIS OF Min Wu for the degree of Master ofScience in Pharmacy presented on September 13, 1996. Title:Novel Bioactive Secondary Metabolites from the Marine CyanobacteriumLyngbya majuscula Abstract ved: Redacted for Privacy William H, Gerwick Marine algae have been recognized as arich resource of new and unusual organic molecules withdiverse biological properties. The current need to develop new antifungal,anticancer, antibiotic and antiviral drugs has led to an intenseresearch effort into the discovery, isolation and structure determinationof potential medicinal agents from marine algae. In the past two years, I have participatedin a drug discovery program designed forantitumor, antifungal and other agents of potential pharmaceutical utility from themarine cyanobacterium Lyngbya majuscula. This research utilized modernchromatographic and spectrochemical techniques including2D NMR spectroscopy. Brine shrimp toxicity guided the fractionationthat led to the discovery of the biologically activecompound kalkitoxin from a Curacao Lyngbya majuscula extract.The structure of this new thiazoline ring-containing lipid wasdetermined spectroscopically by interpretation of 2D-NMR experiments,including heteronuclear multiple quantum coherence (HMQC),heteronuclear multiple-bond coherence spectroscopy (HMBC) and'H-'H COSY at room temperature and elevated temperature.Kalkitoxin shows modest molluscicidal toxicity, good brine shrimptoxicity and extremely potent ichthyotoxicity. From the same extract of Lyngbyamajuscula, I also isolated
    [Show full text]
  • Shellfish Toxins Targeting Voltage-Gated Sodium Channels
    Mar. Drugs 2013, 11, 4698-4723; doi:10.3390/md11124698 OPEN ACCESS marine drugs ISSN 1660-3397 www.mdpi.com/journal/marinedrugs Review Shellfish Toxins Targeting Voltage-Gated Sodium Channels Fan Zhang, Xunxun Xu, Tingting Li and Zhonghua Liu * Cooperative Innovation Center of Engineering and New Products for Developmental Biology, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China; E-Mails: [email protected] (F.Z.); [email protected] (X.X.); [email protected] (T.L.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +86-731-88-872-556; Fax: +86-731-88-861-304. Received: 12 September 2013; in revised form: 10 November 2013 / Accepted: 12 November 2013 / Published: 28 November 2013 Abstract: Voltage-gated sodium channels (VGSCs) play a central role in the generation and propagation of action potentials in excitable neurons and other cells and are targeted by commonly used local anesthetics, antiarrhythmics, and anticonvulsants. They are also common targets of neurotoxins including shellfish toxins. Shellfish toxins are a variety of toxic secondary metabolites produced by prokaryotic cyanobacteria and eukaryotic dinoflagellates in both marine and fresh water systems, which can accumulate in marine animals via the food chain. Consumption of shellfish toxin-contaminated seafood may result in potentially fatal human shellfish poisoning. This article provides an overview of the structure, bioactivity, and pharmacology of shellfish toxins that act on VGSCs, along with a brief discussion on their pharmaceutical potential for pain management. Keywords: VGSCs; shellfish toxins; structure; bioactivity; pharmaceutical potential 1. Overview of Voltage-Gated Sodium Channels Voltage-gated sodium channels (VGSCs) are transmembrane proteins that form ion channels, conducting sodium ion (Na+) through the cell plasma membrane upon activation.
    [Show full text]
  • Antillatoxin Is a Sodium Channel Activator That Displays Unique Efficacy in Heterologously Expressed Rnav1.2, Rnav1.4 and Rnav1.5 Alpha Subunits
    UC San Diego UC San Diego Previously Published Works Title Antillatoxin is a sodium channel activator that displays unique efficacy in heterologously expressed rNav1.2, rNav1.4 and rNav1.5 alpha subunits Permalink https://escholarship.org/uc/item/2m7347pf Journal BMC Neuroscience, 11(1) ISSN 1471-2202 Authors Cao, Zhengyu Gerwick, William H Murray, Thomas F Publication Date 2010-12-14 DOI http://dx.doi.org/10.1186/1471-2202-11-154 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Cao et al. BMC Neuroscience 2010, 11:154 http://www.biomedcentral.com/1471-2202/11/154 RESEARCH ARTICLE Open Access Antillatoxin is a sodium channel activator that displays unique efficacy in heterologously expressed rNav1.2, rNav1.4 and rNav1.5 alpha subunits Zhengyu Cao1,3, William H Gerwick2, Thomas F Murray1* Abstract Background: Antillatoxin (ATX) is a structurally unique lipopeptide produced by the marine cyanobacterium Lyngbya majuscula. ATX activates voltage-gated sodium channel a-subunits at an undefined recognition site and stimulates sodium influx in neurons. However, the pharmacological properties and selectivity of ATX on the sodium channel a-subunits were not fully characterized. Results: In this study, we characterized the pharmacological properties and selectivity of ATX in cells + heterologously expressing rNav1.2, rNav1.4 or rNav1.5 a-subunits by using the Na selective fluorescent dye, sodium-binding benzofuran isophthalate. ATX produced sodium influx in cells expressing each sodium channel a- subunit, whereas two other sodium channel activators, veratridine and brevetoxin-2, were without effect. The ATX potency at rNav1.2, rNav1.4 and rNav1.5 did not differ significantly.
    [Show full text]
  • Diversity and Impact of Prokaryotic Toxins on Aquatic Environments: a Review
    Toxins 2010, 2, 2359-2410; doi:10.3390/toxins2102359 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Diversity and Impact of Prokaryotic Toxins on Aquatic Environments: A Review Elisabete Valério 1, Sandra Chaves 2 and Rogério Tenreiro 2,* 1 Centro de Recursos Microbiológicos (CREM), Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Quinta da Torre, 2829-516 Caparica, Portugal; E-Mail: [email protected] 2 Centro de Biodiversidade, Genómica Integrativa e Funcional (BioFIG), Faculdade de Ciências, Universidade de Lisboa, Edificio ICAT, Campus da FCUL, Campo Grande, 1740-016 Lisboa, Portugal; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +351-21-750-00-06; Fax: +351-21-750-0172. Received: 21 August 2010; in revised form: 1 October 2010 / Accepted: 13 October 2010 / Published: 18 October 2010 Abstract: Microorganisms are ubiquitous in all habitats and are recognized by their metabolic versatility and ability to produce many bioactive compounds, including toxins. Some of the most common toxins present in water are produced by several cyanobacterial species. As a result, their blooms create major threats to animal and human health, tourism, recreation and aquaculture. Quite a few cyanobacterial toxins have been described, including hepatotoxins, neurotoxins, cytotoxins and dermatotoxins. These toxins are secondary metabolites, presenting a vast diversity of structures and variants. Most of cyanobacterial secondary metabolites are peptides or have peptidic substructures and are assumed to be synthesized by non-ribosomal peptide synthesis (NRPS), involving peptide synthetases, or NRPS/PKS, involving peptide synthetases and polyketide synthases hybrid pathways.
    [Show full text]
  • Neurotoksyny Syntetyzowane Przez Sinice
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Jagiellonian Univeristy Repository Wiadomości Botaniczne 52(3/4): 43–53, 2008 Neurotoksyny syntetyzowane przez sinice Jan BIAŁCZYK, Zbigniew LECHOWSKI, Beata BOBER BIAŁCZYK J., LECHOWSKI Z., BOBER B. 2008. Neurotoxins synthesized by cyanobacteria. Wiadomości Botaniczne 52(3/4): 43–53. Cyanobacterial neurotoxins constitute one of the most toxic substances synthesized by living organisms. They are characterised by an unusually quick action that brings about the death of humans or animals within seconds or a few minutes of their consumption without the possi- bility of administering an antidote. The mechanism by which they act involves disturbance of the process of Na+ ions transportation in the neuromuscular systems. The neurotoxins contain nitrogen in their composition and are mostly alkaloids. They are synthesized by cyanobacteria living at all ecological niches. Certain species of free-living cyanobacteria (for example, Cy- lindrospermopsis raciborskii, Scytonema sp.) or those entering into symbiosis with plants (for example Nostoc sp.) produce β-methylaminoalanine. This non-protein amino acid may act as a ‘slow toxin’ inducing neurodegenerative diseases (amyotrophic lateral sclerosis, parkinsonism, dementia complex). The article discusses the classifi cation and chemical composition of cy- anobacterial neurotoxins, the mechanism of their action as well as the environmental threats that arise with the appearance of cyanobacterial blooms. KEY WORDS: cyanobacterial blooms, secondary metabolites, toxins Jan Białczyk, Zbigniew Lechowski, Beata Bober, Zakład Fizjologii i Biologii Rozwoju Roślin Uniwersytetu Jagiellońskiego, ul. Gronostajowa 7, 30-386 Kraków, e-mail: [email protected] WSTĘP z pól (Antoniou et al.
    [Show full text]
  • Incubators, Ovens and Water Baths
    Principal Investigator/Program Director (Last, First, Middle): (BERWICK, William Herllly RESOURCES FOR MARINE ALGAL CONSULTANT VALERIE PAUL FACILITIES: Specify the facilities to be used for the conduct of the proposed research. indicate the performance sites and describe capacities, pertinent capabilities, relative proximity, and extent of availability tothe project. Under "Other," identify support services such as machine shop, electronics shop, and specify the extent to which they will be available to the project. Use continuation pages if necessary. Laboratory: The Smithsonian Marine Station is a research facility located on the intracoastal waterway in Fort Pierce, FL. Laboratory space is available in a laboratory/office building (8000 sq ft). My individual research space is available in a laboratory (220 sq ft) that houses chemical instrumentation, computers, analytical balances and all supplies for isolating and quantifying marine natural products. A multi-user chemistry laboratory (420 sq ft) is available for additional chemical research, and another shared laboratory houses freezers, freeze drier, speed-vac, ovens and other laboratory equipment. A multi- user molecular laboratory and facilities for microscopy (confocal, light, SEM, TEM) are also available. Clinical: N/A Animal: A wet laboratory is available with filtered, recirculating sea water supply for holding marine organisms. Temperature-controlled aquaria and incubators are also in the wet laboratory. Computer: My personal and laboratory computers and a general use computer laboratory with 6 computers and printers are available. All are of recent vintage and have the normal complement of software (Microsoft Office and necessary statistical, graphics and other software packages). All computers are connected to dedicated ink-jet/laserjet printers and are networked to color laser printers within the computer laboratory.
    [Show full text]
  • Neurotoxicity of Cyanobacterial Toxins
    ENVIRONMENTAL BIOTECHNOLOGY 10 (1) 2014 , 26-43; doi:10.14799/ebms246 Neurotoxicity of cyanobacterial toxins Maciej Florczyk, Alicja Łakomiak, Maciej Woêny, Paweł Brzuzan Department of Environmental Biotechnology, Faculty of Environmental Sciences, University of Warmia and Mazury in Olsztyn, Poland Corresponding author: Maciej Florczyk, Department of Environmental Biotechnology, Faculty of Environmental Sciences, University of Warmia and Mazury in Olsztyn, Słoneczna 45G, 10-709 Olsztyn, Poland; Phone: +48 89 523 4164; Fax: +48 89 523 4131; E-mail: [email protected] Keywords: blue-green algae, cyanotoxins, drugs, medicine, microcystin, neurotoxicity Received in July 2014. Published in December 2014. ABSTRACT changes in protein phosphatase activity. These effects have been partially explained by the discovery in the blood-brain Eutrophication of marine- and fresh-waters can lead to excessive barrier of the same membrane transporters involved in development of cyanobacterial blooms, which may contain microcystins hepatotoxic mechanisms. Additionally, this paper strains that produce toxins. These toxins are secondary reviews other cyanotoxins that are known or suspected to target metabolites which can accumulate in the food chain and cholinergic synapses and voltage-gated channels, including contaminate drinking water, thus posing a potential threat to the anatoxin-a, anatoxin-a(s), antillatoxins, cylindrospermopsin, health of humans and aquatic organisms. These toxins include homoanatoxin-a, jamaicamide, kalkitoxin and saxitoxins. The a variety of compounds with different mechanisms. This review neurotoxic and cytotoxic effects of the cyanotoxins discussed focuses on the neurotoxicity of microcystin and other here are of particular interest because of their pharmacological cyanotoxins. Although the hepatotoxic action of microcystins is potential. This review also discusses the potential of these commonly known, its neurotoxic effects have also been compounds to serve as drugs for cancer and central nervous described, e.g.
    [Show full text]